# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2571-2580 of 2727 results.
A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors
Status: Active, not recruiting
Last Changed: Oct 14, 2020
First Received: Mar 07, 2017
Disease(s): Advanced Solid Tumors Cancer
Intervention(s): ABBV-368, ABBV-181
Locations: Moore UC San Diego Cancer Center /ID# 201334, La Jolla, California, United States
University of California, Davis Comprehensive Cancer Center /ID# 201342, Sacramento, California, United States
Stanford University /ID# 206949, Stanford, California, United States
Yale University /ID# 207895, New Haven, Connecticut, United States
Carolina BioOncology Institute /ID# 160786, Huntersville, North Carolina, United States
... and 23 other locations.
Safety of ABM-1310 Monotherapy in Patients With Advanced Solid Tumors
Status: Recruiting
Last Changed: Aug 19, 2020
First Received: Dec 09, 2019
Disease(s): Advanced Solid Tumor, BRAF V600 Mutation
Intervention(s): ABM-1310
Locations: Henry Ford Cancer Institute, Detroit, Michigan, United States
Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, Nevada, United States
MD Anderson Cancer Center, Houston, Texas, United States
INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies
Status: Completed
Last Changed: Jul 22, 2020
First Received: Sep 11, 2017
Disease(s): Advanced Malignancies, Metastatic Cancer
Intervention(s): INCAGN01876, Epacadostat, Pembrolizumab
Locations: The Angeles Clinic and Research Institute, Los Angeles, California, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer
Status: Completed
Last Changed: Feb 09, 2016
First Received: Feb 21, 2011
Disease(s): Metastatic Cancer, Cancer, Solid Tumors
Intervention(s): BIND-014
Locations: Investigational Site #01, Scottsdale, Arizona, United States
Investigational Site #02, Greenbrae, California, United States
Investigational Site #04, Los Angeles, California, United States
Investigational Site #06, Fort Meyers, Florida, United States
Investigational Site #03, Detriot, Michigan, United States
... and 2 other locations.
A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors
Status: Terminated
Last Changed: Sep 13, 2018
First Received: Oct 16, 2012
Disease(s): PIK3CA Mutated Advanced Solid Tumors, PIK3CA Amplified Advanced Solid Tumors
Intervention(s): BYL719, AMG 479
Locations: Novartis Investigative Site, Los Angeles, California, United States
Novartis Investigative Site, Boston, Massachusetts, United States
Novartis Investigative Site, New York, New York, United States
Novartis Investigative Site, Nashville, Tennessee, United States
Novartis Investigative Site, Leuven, Belgium
... and 6 other locations.
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Status: Recruiting
Last Changed: Oct 19, 2020
First Received: Aug 17, 2018
Disease(s): Solid Tumors
Intervention(s): RMC-4630
Locations: Honor Health Research Institute, Scottsdale, Arizona, United States
City of Hope, Duarte, California, United States
UC Irvine - Chao Family Comprehensive Cancer Center, Orange, California, United States
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
UC San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
... and 8 other locations.
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Status: Active, not recruiting
Last Changed: Sep 11, 2020
First Received: Dec 22, 2016
Disease(s): Advanced Solid Tumors
Intervention(s): Venetoclax, Rovalpituzumab Tesirine, ABBV-181
Locations: Ucsd /Id# 157374, La Jolla, California, United States
University of Chicago /ID# 157375, Chicago, Illinois, United States
Carolina BioOncology Institute /ID# 157376, Huntersville, North Carolina, United States
South Texas Accelerated Research Therapeutics /ID# 157378, San Antonio, Texas, United States
Virginia Cancer Specialists /ID# 157377, Fairfax, Virginia, United States
... and 22 other locations.
Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Status: Active, not recruiting
Last Changed: Jul 21, 2020
First Received: Apr 24, 2017
Disease(s): Advanced Malignancies, Metastatic Cancer
Intervention(s): INCAGN01876, Nivolumab, Ipilimumab
Locations: The Angeles Clinic and Research Institute, Los Angeles, California, United States
University of Florida, Gainesville, Florida, United States
Karmanos Cancer Institute, Detroit, Michigan, United States
Washington University - Siteman Cancer Center, Saint Louis, Missouri, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
... and 39 other locations.
Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer
Status: Withdrawn
Last Changed: Jun 28, 2011
First Received: May 22, 2006
Disease(s): Gynecologic Neoplasms
Intervention(s): Regular diet as the first postoperative meal
Locations: Department of OB-GYN, Faculty of Medicine, Chiang Mai University, Muang Chiangmai, Chiang Mai, Thailand
A Study of ASP1948, Targeting an Immune Modulatory Receptor, in Subjects With Advanced Solid Tumors
Status: Recruiting
Last Changed: Sep 01, 2020
First Received: Jun 21, 2018
Disease(s): Advanced Solid Tumors
Intervention(s): ASP1948, nivolumab, pembrolizumab
Locations: Yale Center for Clinical Investigation, New Haven, Connecticut, United States
Augusta University, Augusta, Georgia, United States
University of Chicago, Chicago, Illinois, United States
Norton Cancer Institute, Louisville, Kentucky, United States
Cancer Center at Greater Baltimore Medical, Baltimore, Maryland, United States
... and 33 other locations.